Across all patients included, mean eGFR was 78.5 mL/min/1.73 m2 (SD: 18.46) and median UACR was 8.1 mL/min/1.73 m2 (IQR: 4.1–20.7), and a higher proportion of patients with CKD were on either an angiotensin converting enzyme (ACE) inhibitor or an angiotensin II receptor blocker (ARB) by the time they were diagnosed with diabetes (p<0.0001). The gene discussed is ACE; the disease is chronic kidney disease.